Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Not applicable Interventional

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

ClinicalTrials.gov ID: NCT04419779

Public ClinicalTrials.gov record NCT04419779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agents. The purpose of this study is to demonstrate the efficacy and safety of the Fractyl DMR Procedure using the Revita® System compared to a sham. Subjects randomized to the DMR procedure will be followed per protocol till 48 weeks post treatment. Subjects in the Sham treatment arm will be offered cross over to receive the DMR treatment at 48 weeks and will be followed per protocol for 48 weeks post treatment.

Study identification

NCT ID
NCT04419779
Recruitment status
Suspended
Study type
Interventional
Phase
Not applicable
Lead sponsor
Fractyl Health Inc.
Industry
Enrollment
320 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 8, 2021 (Actual)
Primary completion
Jan 2026 (Estimated)
Completion
Jan 2026 (Estimated)
Last update posted
Nov 13, 2025

2021 – 2026

United States locations

U.S. sites
51
U.S. states
19
U.S. cities
42
Facility City State ZIP Site status
Helios CR, Inc Phoenix Arizona 85028 —
HonorHealth Research Institute Scottsdale Arizona 85258 —
Mayo Clinic Arizona Scottsdale Arizona 85259 —
Angel City Research , Inc. Los Angeles California 90010 —
UCLA Health Los Angeles California 90095 —
Care Access Santa Clarita Newhall California 91321 —
Hoag Hospital Newport Beach California 92663 —
Stanford University Medical Center Redwood City California 94063 —
Mills Peninsula Health Center San Mateo California 94401 —
Northeast Research Institute, Llc Fleming Island Florida 32003 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
University of Miami Miami Florida 33136 —
West Orange Endocrinology Ocoee Florida 34761 —
Advent Health Orlando Orlando Florida 32804 —
Synexus Research Orlando Florida 32806 —
Northwestern Unviersity Evanston Illinois 60611 —
AHN - Avon Avon Indiana 46123 —
Investigators Research Group Brownsburg Indiana 46112 —
AHN- Franklin Franklin Indiana 46131 —
AHN - Greenfield Greenfield Indiana 46140 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
AHN - Muncie Muncie Indiana 47304 —
University of Louisville Louisville Kentucky 40202 —
Tulane University New Orleans Louisiana 70112 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Alcanza Clinical Research, LLC Methuen Massachusetts 01844 —
University of Michigan Ann Arbor Michigan 48109 —
Jefferson City Medical Group Jefferson City Missouri 65109 —
Washington University School of Medicine St Louis Missouri 63110 —
IMA Clinical Research St. Louis St Louis Missouri 63117 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Endocrine Associates of West Village Long Island City New York 77089 —
NYU Langone Gastroenterology Associates New York New York 10016 —
Synexus Clinical Research, New York New York New York 10017 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Weill Cornell Medicine New York New York 10065 —
Duke University Medical Center Durham North Carolina 27710 —
M3 Wake Research Raleigh North Carolina 27612 —
AcellaCare Salisbury Salisbury North Carolina 28144 —
AcellaCare Piedmont Statesville North Carolina 28625 —
AcellaCare Wilmington Wilmington North Carolina 28401 —
Cleveland Clinic Cleveland Ohio 44195 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Preferred PCP - Pittsburgh Pittsburgh Pennsylvania 15201 —
Preferred Primary Care Physicians Pittsburgh Pennsylvania 15236 —
Care Access Warwick Warwick Rhode Island 02886-4463 —
Baylor St. Luke's Medical Center Houston Texas 77030 —
Biopharma Informatic, Llc Houston Texas 77089 —
Simcare Medical Research, Llc. Sugar Land Texas 77478 —
Seattle Cancer Care Alliance Seattle Washington 98104 —
West Virginia University Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04419779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04419779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →